InsiderClue
Insiders · Profile

Robinson Chandler

Chief Executive Officer at Monopar Therapeutics. Filing since 14 Jul 2025. CIK 0001727334

Company
Date
Role
Action
Shares
Amount
Of holding
MNPR Monopar Therapeutics
24 Sep 2026
Chief Executive Officer
Sold on a plan
29,056
$2.56M
22.6%
MNPR Monopar Therapeutics
14 Jul 2025
Chief Executive Officer
Sold at will
16,800
$672.02K
18.6%
2 decisions on file.